Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 32 of 1,261
  1. US 12351625

    Therapeutic antibodies against osteopontin

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  2. US 12351834

    Compositions and methods for the treatment of ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  3. US 12351614

    CLEC9A-based chimeric protein complexes

    Orionis Biosciences, Inc · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  4. WO 2025143118

    COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT D'UNE LÉSION DE LA MOELLE ÉPINIÈRE ET PROCÉDÉ DE PRODUCTION D'UN MODÈLE ANIMAL DE PRIMATE NON HUMAIN POUR UNE LÉSION DE LA MOELLE ÉPINIÈRE

    ASTELLAS PHARMA INC [JP] · Granted Jul 3, 2025 · Expires Jun 28, 2045

    granted
  5. US 12343398

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  6. US 12344578

    Salt forms of bempedoic acid and methods for using the same

    Esperion Therapeutics, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  7. US 12343397

    Drug-resistant immune cells and methods of use thereof

    Regents of the University of Minnesota · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  8. US 12344596

    Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  9. US 12344654

    Mage A4 T cell receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  10. US 12343432

    Encapsulated probiotic

    UNITED ARAB EMIRATES UNIVERSITY · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  11. US 12343388

    Clostridioides difficile TcdB variants, vaccines and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  12. US 12343394

    CD38 modulating antibody agents

    BLACK BELT THERAPEUTICS LIMITED · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  13. US 12343324

    Dihydromyricetin hot melt extrusion formulations and methods for forming them

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  14. US 12343337

    Compounds for increasing neural plasticity

    The Regents of the University of California · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  15. US 12344665

    Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  16. US 12343342

    Methods for treating soft tissue sarcoma

    Lixte Biotechnology, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  17. US 12344655

    Gene-edited natural killer cells

    CRISPR THERAPEUTICS AG · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  18. US 12343424

    Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  19. US 12344691

    Resin composition for stereolithography

    KURARAY NORITAKE DENTAL INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  20. US 12344676

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  21. US 12344842

    Compositions and methods for treating and preventing macular degeneration

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  22. US 12343357

    Compositions and methods for modulating MECP2 expression

    Ionis Pharmaceuticals, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  23. US 12343348

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  24. US 12343321

    Method for ameliorating or avoiding the adverse effects of exogenous gonadotropins on reproductive performance

    China Agricultural University · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.